By Nqobile Dludla JOHANNESBURG, July 15 (Reuters) - India's Sun Pharmaceutical Industries has received approval from South ...

Sun Pharmaceutical shares hit a 52-week high after receiving approval to market generic semaglutide injection in South Africa ...

The generic semaglutide will be available as a pre-filled, multi-dose injectable pen in two strengths, 2 mg/1.5 mL and 4 mg/3 ...

Stock of Sun Pharmaceutical is in focus as the company’s shares are set to turn ex- dividend tomorrow with its final dividend ...

Sun Pharma receives SAHPRA approval to market a generic semaglutide injection for type 2 diabetes in South Africa.

Sun Pharmaceutical Industries Ltd. 524715 shares inched up 0.30% to 1,871.55 Indian rupees Thursday, on what proved to be an all-around positive trading session for the stock market, with the BSE ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The country’s largest lender, State Bank of India (SBI), and 10 other global banks, have combined forces to finance one of ...

Get Sun Pharmaceutical Industries latest Profit & Loss account, Income Statement, Financial Statements and Sun Pharmaceutical Industries detailed profit and loss accounts including income, expenses, ...

Sun Pharma drew more unwanted attention this week when India’s stock regulators confirmed they are examining whistleblower allegations against the company. “We have received the complaint against Sun ...

After navigating a series of manufacturing problems in recent months, Sun Pharma has now been forced to respond to an entirely different type of issue. Last week, Mumbai, India-based Sun Pharma ...